These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17426445)

  • 1. A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors.
    Lin X; Huang H; Li S; Li H; Li Y; Cao Y; Zhang D; Xia Y; Guo Y; Huang W; Jiang W
    Cancer Biol Ther; 2007 May; 6(5):648-53. PubMed ID: 17426445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors.
    Li HL; Li S; Shao JY; Lin XB; Cao Y; Jiang WQ; Liu RY; Zhao P; Zhu XF; Zeng MS; Guan ZZ; Huang W
    Gene Ther; 2008 Feb; 15(4):247-56. PubMed ID: 18097470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical tolerance trial on recombinant human endostatin adenovirus].
    Cao Y; Li S; Li HL; Li YH; Zhang DS; Guo Y; Li XL; Lin XB; Huang WL; Jiang WQ
    Ai Zheng; 2007 Aug; 26(8):856-60. PubMed ID: 17697547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term toxicity studies in Canine of E10A, an adenoviral vector for human endostatin gene.
    Huang BJ; Liu RY; Huang JL; Liang ZH; Gao GF; Wu JX; Huang W
    Hum Gene Ther; 2007 Mar; 18(3):207-21. PubMed ID: 17346097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
    Adhim Z; Lin X; Huang W; Morishita N; Nakamura T; Yasui H; Otsuki N; Shigemura K; Fujisawa M; Nibu K; Shirakawa T
    Cancer Gene Ther; 2012 Feb; 19(2):144-52. PubMed ID: 22116375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinoma.
    Ye W; Liu R; Pan C; Jiang W; Zhang L; Guan Z; Wu J; Ying X; Li L; Li S; Tan W; Zeng M; Kang T; Liu Q; Thomas GR; Huang M; Deng W; Huang W
    Mol Ther; 2014 Jun; 22(6):1221-1229. PubMed ID: 24662947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors.
    Thomas JP; Arzoomanian RZ; Alberti D; Marnocha R; Lee F; Friedl A; Tutsch K; Dresen A; Geiger P; Pluda J; Fogler W; Schiller JH; Wilding G
    J Clin Oncol; 2003 Jan; 21(2):223-31. PubMed ID: 12525513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases.
    Zhao P; Luo R; Wu J; Xie F; Li H; Xiao X; Fu L; Zhu X; Liu R; Zhu Y; Liang Z; Huang W
    J Cell Mol Med; 2010 Jan; 14(1-2):381-91. PubMed ID: 26065034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and Pharmacokinetics of Recombinant Human Endostatin Administered as Single-Dose or Multiple-Dose Infusions in Patients With Advanced Solid Tumors: A Phase I Clinical Trial.
    Wang X; Shi Y; Jia Y; Zhao W; Zhang L; Bai G; Ren Y; Chen YZ; Tong Z
    Technol Cancer Res Treat; 2021; 20():15330338211064434. PubMed ID: 34931914
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders.
    Chen S; Guo D; Guo B; Liu J; Shen Y; Xu X; Huang W; Guo S
    Int J Pharm; 2012 May; 427(2):145-52. PubMed ID: 22234038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.
    Sangro B; Mazzolini G; Ruiz J; Herraiz M; Quiroga J; Herrero I; Benito A; Larrache J; Pueyo J; Subtil JC; Olagüe C; Sola J; Sádaba B; Lacasa C; Melero I; Qian C; Prieto J
    J Clin Oncol; 2004 Apr; 22(8):1389-97. PubMed ID: 15084613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice.
    Wen XY; Bai Y; Stewart AK
    Hum Gene Ther; 2001 Mar; 12(4):347-58. PubMed ID: 11242527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitory effect of adenovirus-mediated endostatin gene transfer on transplanted lung carcinoma in mice].
    Sui G; Xu ZF; Sun YC; Liu YJ; Wu LH; Qin X
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):93-6. PubMed ID: 18646688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactivity and stability analysis of endostatin purified from fermentation supernatant of 293 cells transfected with Ad/rhEndo.
    Liang Z; Wu J; Huang J; Tan W; Ke M; Liu R; Huang B; Xiao X; Zhao P; Huang W
    Protein Expr Purif; 2007 Dec; 56(2):205-11. PubMed ID: 17933553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients.
    Li JL; Liu HL; Zhang XR; Xu JP; Hu WK; Liang M; Chen SY; Hu F; Chu DT
    Gene Ther; 2009 Mar; 16(3):376-82. PubMed ID: 19092859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated intra-tumoral delivery of the human endostatin gene inhibits tumor growth in nasopharyngeal carcinoma.
    Li L; Liu RY; Huang JL; Liu QC; Li Y; Wu PH; Zeng YX; Huang W
    Int J Cancer; 2006 Apr; 118(8):2064-71. PubMed ID: 16287067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I dose-escalating trial of Escherichia coli purine nucleoside phosphorylase and fludarabine gene therapy for advanced solid tumors.
    Rosenthal EL; Chung TK; Parker WB; Allan PW; Clemons L; Lowman D; Hong J; Hunt FR; Richman J; Conry RM; Mannion K; Carroll WR; Nabell L; Sorscher EJ
    Ann Oncol; 2015 Jul; 26(7):1481-7. PubMed ID: 25899782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery.
    Li L; Huang JL; Liu QC; Wu PH; Liu RY; Zeng YX; Huang WL
    World J Gastroenterol; 2004 Jul; 10(13):1867-71. PubMed ID: 15222025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
    Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
    Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor.
    Ponnazhagan S; Mahendra G; Kumar S; Shaw DR; Stockard CR; Grizzle WE; Meleth S
    Cancer Res; 2004 Mar; 64(5):1781-7. PubMed ID: 14996740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.